Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2006-08-29
2006-08-29
McKenzie, Thomas C. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C514S250000
Reexamination Certificate
active
07098337
ABSTRACT:
The present invention relates to compounds of formula (I)as well as pharmaceutically acceptable salts, solvates and esters thereof. These compounds can be used to prepare pharmaceutical compositions for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes, obesity and sleep apnoea.
REFERENCES:
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 4931463 (1990-06-01), Barbier et al.
patent: 4983746 (1991-01-01), Barbier et al.
patent: 5245056 (1993-09-01), Karpf et al.
patent: 6004996 (1999-12-01), Shah et al.
patent: 6495543 (2002-12-01), Guillamet et al.
patent: 185359 (1986-06-01), None
patent: 189577 (1986-08-01), None
patent: 443449 (1991-08-01), None
patent: 524495 (1993-01-01), None
patent: WO 99/34786 (1999-07-01), None
patent: WO 00/09122 (2000-02-01), None
patent: WO 00/09123 (2000-02-01), None
patent: WO 00/44753 (2000-08-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Bickerdike MJ., Curr Top Med Chem. 2003;3(8):885-97, Abstract only, PMID: 12678838.
Jones BJ, Blackburn TP., Pharmacol Biochem Behav. Apr. 2002; 71(4):555-68.
Serretti A, Artioli P, De Ronchi D., Expert Opin Ther Targets. Feb. 2004;8(1):15-23.
Kimura Y, Hatanaka K, Naitou Y, Maeno K, Shimada I, Koakutsu A, Wanibuchi, F. Yamaguchi T., Eur J Pharmacol. Jan. 1, 2004;483(1)37-43.
Keller & Wahli, Trends Endocrin. Metab. 1993; vol. 4: pp. 291-296.
Macdonald & Lane, Current Biology vol. 5, pp. 618-621 (1995).
Eur. J. Pharmacol. Jul. 20, 2001, vol. 424(2), pp. 85-90.
Psychopharmacol. Bull. 1989. vol. 25(3) pp. 393-397.
Adams David Reginald
Bentley Jonathan Mark
Blench Toby Jonathan
Hebeisen Paul
Monck Nathaniel Julius Thomas
Hoffmann-La Roche Inc.
Johnston George W.
McKenzie Thomas C.
Megerditchian Samuel H.
Tramaloni Dennis P.
LandOfFree
1,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,3,4,9,9a-hexahydro-2,4a,5-triaza-fluorene and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3716768